RECORDED WEBINAR (30 min)
Biopharmaceutical drug development: from CMC to clinical PK
An overview of Gyrolab® immunoassays and their utility in CMC target binding assays for batch release and stability assessment. Also, for preclinical and clinical PK analysis with a view to transferring assays to a CRO.
This webinar will give an overview of a Gyrolab system and how it is used to support biopharmaceutical drug development. Uses include bioprocess application and pharmacokinetic assays. A case study from Symphogen will highlight how a Gyrolab 2-plex assay can be used to support a program for a therapeutic antibody mixture. The case study will highlight the advantages of speed, data quality and ease of transferring an assay to a CRO.
What will you learn?
- How to maximize the performance and productivity of automated ligand-binding assays
- How automated ligand-binding assays of two monoclonal antibodies can lead to efficient assay development and validation
- How transferring a ligand-binding assay to a CRO can be made easier